› › Ionis Pharmaceuticals

IONS

Ionis Pharmaceuticals News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.46 1.25% 37.14 00:00:13
Open Price Low Price High Price Close Price Prev Close
36.56 36.555 37.825 37.14 36.68
more quote information »

Recent News

Date Time Source Heading
7/29/202107:47SEEKIonis completes enrollment in late-stage eplontersen..
7/29/202107:05PRNUSIonis completes enrollment in pivotal NEURO-TTRansform study..
7/26/202117:01SEEKBiogen and Ionis post promising data from early-stage..
7/26/202116:35PRNUSBiogen and Ionis report positive topline clinical data on..
7/21/202107:05PRNUSIonis to hold second quarter 2021 financial results webcast
7/13/202107:27SEEKIonis inks licensing deal with Bicycle Therapeutics to..
7/13/202106:59PRNUSIonis enters exclusive licensing agreement with Bicycle..
7/06/202117:53EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:53EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:52EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:52EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:52EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:52EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:51EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202117:51EDGARStatement of Changes in Beneficial Ownership (4)
6/25/202117:20EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202117:05EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202118:46EDGARStatement of Changes in Beneficial Ownership (4)
6/14/202116:05PRNUSIonis' Chief Scientific Officer C. Frank Bennett, Ph.D.,..
6/10/202118:05PRNUSIonis' antisense therapies in ATTR amyloidosis to be..
6/10/202108:48DJNBiogen: Research Supports Development of Investigational..
6/10/202107:30GLOBENew Data at Cure SMA 2021 Highlight the Long-Term Efficacy..
6/09/202119:02EDGARInitial Statement of Beneficial Ownership (3)
6/04/202116:44EDGARCurrent Report Filing (8-k)
6/02/202119:59PRNUSIonis announces changes to its board of directors at annual..
5/26/202107:05PRNUSIonis to present at upcoming investor conferences
5/20/202116:28EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/06/202107:05PRNUSIonis to present at upcoming investor conferences
5/05/202116:05PRNUSIonis to host 2021 virtual annual meeting of stockholders
5/05/202114:59EDGARQuarterly Report (10-q)
5/05/202111:16EDGARCurrent Report Filing (8-k)
5/05/202108:06SEEKIonis Pharma trails Q1 consensus; top-line off 16%
5/05/202107:02SEEKIonis Pharmaceuticals EPS misses by $0.09, misses on revenue
5/05/202107:00PRNUSIonis reports first quarter 2021 financial results and..
5/04/202114:05SEEKIonis Pharmaceuticals Q1 2021 Earnings Preview
4/21/202107:05PRNUSIonis to hold first quarter 2021 financial results webcast
4/20/202107:32SEEKIonis begins pivotal study for ION373 in rare congenital..
4/20/202107:05PRNUSIonis initiates pivotal clinical study of novel antisense..
4/19/202117:05EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202107:30GLOBEBiogen Advances Leading Research in Spinal Muscular Atrophy..
4/13/202106:06EDGARCurrent Report Filing (8-k)
4/08/202107:26SEEKIonis Pharmaceuticals prices upsized $550M convertible..
4/08/202107:05PRNUSIonis prices private placement of convertible senior notes
4/06/202116:36PRNUSIonis announces proposed private placement of convertible..
4/06/202108:07SEEKProgenity and Ionis ink collaboration agreement
4/06/202107:01EDGARCurrent Report Filing (8-k)
4/05/202109:02SEEKIonis initiates rare neurodegenerative disorder late-stage..
4/05/202107:05PRNUSIonis initiates Phase 3 trial of novel antisense medicine to..
3/29/202110:24EDGARCurrent Report Filing (8-k)
3/29/202107:32SEEKIonis Pharma's antisense med successful in mid-stage HAE..
See more news about this stock »
Your Recent History
NASDAQ
IONS
Ionis Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210801 08:49:50